• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form POS AM filed by Rockley Photonics Holdings Limited

    2/23/23 4:43:53 PM ET
    $RKLY
    Semiconductors
    Technology
    Get the next $RKLY alert in real time by email
    POS AM 1 d352029dposam.htm POS AM POS AM

    As filed with the Securities and Exchange Commission on February 23, 2023

    Registration No. 333-266077

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    POST-EFFECTIVE AMENDMENT NO. 2

    TO

    FORM S-1

    ON FORM S-3

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    Rockley Photonics Holdings Limited

    (Exact name of registrant as specified in its charter)

     

     

     

    Cayman Islands    3674    98-1644526

    (State or other jurisdiction of

    incorporation or organization)

      

    (Primary Standard Industrial

    Classification Code No.)

      

    (I.R.S. Employer

    Identification No.)

    3rd Floor, 1 Ashley Road

    Altrincham, Cheshire, United Kingdom WA14 2DT

    +44 (0) 1865 292017

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

     

    Tom Adams, Esq.

    General Counsel

    Rockley Photonics Holdings Limited

    3rd Floor, 1 Ashley Road

    Altrincham, Cheshire, United Kingdom WA14 2DT

    +44 (0) 1865 292017

    (Name, address, including zip code, and telephone number, including area code, of agent for service)

     

     

    Copies to:

    James J. Masetti, Esq.

    Davina K. Kaile, Esq.

    Pillsbury Winthrop Shaw Pittman LLP

    2550 Hanover Street

    Palo Alto, CA 94304

    Tel: (650)233-4500

    Fax: (650)233-4545

     

     

    Approximate date of commencement of proposed sale to the public: This post-effective amendment is being filed to deregister the unsold securities previously registered under this Registration Statement.

    If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box:  ☐

    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, please check the following box.  ☐

    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

    If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.  ☐

    If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.  ☐

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

     

    Large accelerated filer   ☐    Accelerated filer   ☐
    Non-accelerated filer   ☒    Smaller reporting company   ☒
         Emerging growth company   ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐

     

     

     


    DEREGISTRATION OF SECURITIES

    This Post-Effective Amendment No. 2 (the “Post-Effective Amendment”) relates to the Registration Statement on Form S-3 (No. 333- 266077) of Rockley Photonics Holdings Limited (the “Registrant”), which was initially filed with the Securities and Exchange Commission on July 11, 2022 and first declared effective on July 27, 2022 (the “Registration Statement”). The Registration Statement was filed with respect to the offer and resale by the selling shareholders named therein from time to time of up to 87,567,895 of the Registrant’s ordinary shares.

    As previously disclosed, on January 23, 2023, the Registrant filed a voluntary petition for relief under chapter 11 of title 11 (the “Chapter 11 Case”) of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”). As a result of the Chapter 11 Case, the Registrant’s obligations to maintain the effectiveness of the Registration Statement shall be deemed canceled and the Registrant has terminated all offerings of securities pursuant to the Registration Statement.

    Pursuant to the undertaking made by the Registrant in the Registration Statement to remove from registration by means of a post-effective amendment any of the securities that had been registered that remain unsold at the termination of the offering, the Registrant is filing this Post-Effective Amendment to terminate the effectiveness of such Registration Statement and to deregister, as of the effectiveness of this Post-Effective Amendment, any and all ordinary shares registered thereunder that remain unsold as of the effectiveness date.


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment No. 2 to be signed on its behalf by the undersigned, thereunto duly authorized in London, United Kingdom, on February 23, 2023.

     

    ROCKLEY PHOTONICS HOLDINGS LIMITED
    By:  

    /s/ Richard A. Meier

      Name:   Richard A. Meier
      Title:   President, Chief Executive Officer and Director

    Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 2 has been signed by the following persons in the capacities and on the dates indicated.

     

    Name

      

    Title

     

    Date

    /s/ Richard A. Meier

       President, Chief Executive Officer and Director   February 23, 2023
    Richard A. Meier    (Principal Executive Officer and Authorized Representative in the United States)  

    /s/ Chad Becker

       Interim Chief Financial Officer   February 23, 2023
    Chad Becker    (Principal Financial and Principal Accounting Officer)  

    /s/ Dr. Andrew Rickman

       Director, Executive Chair   February 23, 2023
    Dr. Andrew Rickman     

    *

       Lead Independent Director   February 23, 2023
    William Huyett     

    *

       Director   February 23, 2023
    Karim Karti     

    *

       Director   February 23, 2023
    Michele Klein     

    *

       Director   February 23, 2023
    Dr. Pamela Puryear     

    *

       Director   February 23, 2023
    Brian Blaser     

    *

       Director   February 23, 2023
    Dr. Nicolaus Henke     

    *

       Director   February 23, 2023
    Dr. Richard Kuntz     

     

    * By:  

    /s/ Tom Adams

      Tom Adams
      Attorney-In-Fact
    Get the next $RKLY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RKLY

    DatePrice TargetRatingAnalyst
    8/12/2022$6.00 → $2.00Outperform → Neutral
    Robert W. Baird
    3/9/2022$20.00 → $10.00Outperform
    Northland Capital Markets
    3/9/2022$6.00 → $5.00Neutral
    B of A Securities
    3/9/2022$15.00 → $8.00Buy
    Needham
    12/22/2021$14.00 → $6.00Buy → Neutral
    B of A Securities
    9/17/2021$14.00Buy
    B of A Securities
    9/9/2021$22.00Outperform
    Cowen
    9/7/2021$15.00Buy
    Needham
    More analyst ratings

    $RKLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Meier Richard A

    4 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)

    10/21/22 5:43:39 PM ET
    $RKLY
    Semiconductors
    Technology

    SEC Form 3 filed by new insider Meier Richard A

    3 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)

    10/21/22 5:22:44 PM ET
    $RKLY
    Semiconductors
    Technology

    SEC Form 4 filed by Kuntz Richard

    4 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)

    8/31/22 6:59:56 PM ET
    $RKLY
    Semiconductors
    Technology

    $RKLY
    SEC Filings

    View All

    SEC Form 15-12G filed by Rockley Photonics Holdings Limited

    15-12G - Rockley Photonics Holdings Ltd (0001852117) (Filer)

    5/15/23 7:44:57 AM ET
    $RKLY
    Semiconductors
    Technology

    SEC Form 10-K filed by Rockley Photonics Holdings Limited

    10-K - Rockley Photonics Holdings Ltd (0001852117) (Filer)

    5/15/23 7:25:35 AM ET
    $RKLY
    Semiconductors
    Technology

    Rockley Photonics Holdings Limited filed SEC Form 8-K: Bankruptcy or Receivership, Material Modification to Rights of Security Holders, Leadership Update, Financial Statements and Exhibits

    8-K - Rockley Photonics Holdings Ltd (0001852117) (Filer)

    4/7/23 4:05:05 PM ET
    $RKLY
    Semiconductors
    Technology

    $RKLY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application

    Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax agency of the UK government. The Company filed its fiscal 2021 R&D tax credit application and expects to file its fiscal 2022 R&D tax credit application in 2023. About Rockley Photonics Formed in 2013, Rockley is a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions that target a portfo

    12/29/22 9:05:00 AM ET
    $RKLY
    Semiconductors
    Technology

    Rockley Photonics Announces Receipt of Notice from NYSE of Non-Compliance with Continued Listing Standards

    Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received a notice from the New York Stock Exchange ("NYSE") on December 9, 2022, indicating that the Company is not in compliance with NYSE's continued listing standards, which require an average market capitalization of not less than $50 million over a 30 trading-day period and stockholders' equity of not less than $50 million. The notice has no immediate impact on the listing of Rockley's common stock on the NYSE, subject to the Company's compliance wit

    12/15/22 4:15:00 PM ET
    $RKLY
    Semiconductors
    Technology

    Rockley Photonics Announces Promotion of Richard A. (Randy) Meier to Chief Executive Officer

    Rickman to serve as executive chair; Becker promoted to interim chief financial officer Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced changes to its senior management team. These changes are intended to position the Company for its next phase of growth. Effective immediately, Richard A. Meier has been appointed president and chief executive officer, and will join the board of directors. Dr. Andrew Rickman has resigned as chief executive officer and will take on the role of executive chairman of Rockley. Chad Becker wi

    12/12/22 4:15:00 PM ET
    $RKLY
    Semiconductors
    Technology

    $RKLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rockley Photonics downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Rockley Photonics from Outperform to Neutral and set a new price target of $2.00 from $6.00 previously

    8/12/22 7:29:27 AM ET
    $RKLY
    Semiconductors
    Technology

    Northland Capital Markets reiterated coverage on Rockley Photonics Hldgs with a new price target

    Northland Capital Markets reiterated coverage of Rockley Photonics Hldgs with a rating of Outperform and set a new price target of $10.00 from $20.00 previously

    3/9/22 11:07:52 AM ET
    $RKLY
    Semiconductors
    Technology

    B of A Securities reiterated coverage on Rockley Photonics Hldgs with a new price target

    B of A Securities reiterated coverage of Rockley Photonics Hldgs with a rating of Neutral and set a new price target of $5.00 from $6.00 previously

    3/9/22 10:40:09 AM ET
    $RKLY
    Semiconductors
    Technology

    $RKLY
    Leadership Updates

    Live Leadership Updates

    View All

    Rockley Photonics Appoints Healthcare Industry Veteran Richard A. "Randy" Meier President and Chief Financial Officer

    Meier to focus on driving cash-efficient performance and enabling commercial production ramp Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global leader in photonics-based health monitoring and communications solutions, today announced the appointment of Richard A. "Randy" Meier as president and chief financial officer (CFO), effective immediately. Meier will shape Rockley's financial and commercialization strategies, and lead its finance, supply chain, quality, regulatory and compliance functions. An accomplished finance and operations leader with a rich background in healthcare therapeutics and medical devices, Meier joins Rockley from Intersect ENT, a leading global ear

    10/20/22 9:37:00 AM ET
    $RKLY
    Semiconductors
    Technology

    Rockley Photonics Names Nicolaus Henke to Board of Directors

    Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it named Nicolaus Henke to its board of directors. Dr. Henke will join the board as an independent director, effective February 16, 2022, and will serve on the Nominating & Corporate Governance Committee. "I am very pleased with the appointment of Nicolaus Henke to our board. He brings a wealth of practical experience which will have an immediate impact on Rockley," said Dr. Andrew Rickman, chairman and chief executive officer of Rockley Photonics. "Throughout his career, Nico has advised top teams in leading health systems, medical device companies and pha

    2/16/22 9:05:00 AM ET
    $RKLY
    Semiconductors
    Technology

    SpartanNash Announces Board Refreshment; Appoints Three New Independent Directors

    Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., Bring Significant Technology, Distribution, Consumer Brand and Human Resources Expertise Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced that, following a comprehensive board refreshment process, three new independent directors, Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., have been appointed to the Company's Board of Directors (the "Board"), effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005303/en/Julien Mininberg (Photo: Business Wire) "Since last summer, our Board has undertaken a deliberate and

    2/7/22 8:15:00 AM ET
    $BALY
    $CLRM
    $HELE
    Hotels/Resorts
    Consumer Discretionary
    Consumer Electronics/Appliances
    Industrials

    $RKLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Rockley Photonics Holdings Limited (Amendment)

    SC 13G/A - Rockley Photonics Holdings Ltd (0001852117) (Subject)

    2/14/23 4:05:33 PM ET
    $RKLY
    Semiconductors
    Technology

    SEC Form SC 13G filed by Rockley Photonics Holdings Limited

    SC 13G - Rockley Photonics Holdings Ltd (0001852117) (Subject)

    2/14/23 4:01:54 PM ET
    $RKLY
    Semiconductors
    Technology

    SEC Form SC 13G filed by Rockley Photonics Holdings Limited

    SC 13G - Rockley Photonics Holdings Ltd (0001852117) (Subject)

    2/14/23 1:23:02 PM ET
    $RKLY
    Semiconductors
    Technology

    $RKLY
    Financials

    Live finance-specific insights

    View All

    Rockley Photonics Reports Third Quarter of Fiscal 2022 Financial Results

    Additional capital raised through private placement Reduction in headcount and operating costs targets lower cash burn Advanced blood pressure biomarker by demonstrating promising intra-subject tracking against standard blood pressure cuff Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced its financial results for the third quarter ended September 30, 2022. During the quarter, the Company advanced its technology platform, Bioptx™, through several technical and clinical targets: Expanded Free-Living Human Study of Its B

    11/9/22 4:15:00 PM ET
    $RKLY
    Semiconductors
    Technology

    Rockley Photonics Announces Date of Third Quarter 2022 Financial Results Release

    Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it plans to report its third quarter 2022 financial results after the market closes on Wednesday, November 9, 2022. The company also plans to host a conference call that day at 5:00 p.m. Eastern Time to review its financial results and business outlook. The conference call can be accessed by dialing 877-407-0832 from the United States or +1 201-689-8433 internationally, referencing Rockley Photonics. A live webcast and replay of the conference call can be accessed from the investor relations page on Rockley's website at investors.rockleyphotonics.com. Follo

    10/26/22 4:15:00 PM ET
    $RKLY
    Semiconductors
    Technology

    Rockley Photonics Reports Second Quarter of Fiscal 2022 Financial Results

    Signs Supply Agreement and Receives First Commercial Purchase Order from Top-Tier Medtech Company for Bioptx™ Baseline Band, Targets Fourth Quarter to Begin Shipping Signs First Contract Research Organization Partnership to Develop and Evaluate Rockley's Bioptx™ Biomarker Sensing Platform for Use in Clinical Trials Bolsters Board of Directors and Establishes Scientific Advisory Board Rockley Photonics Holdings Limited (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced its financial results for the second quarter ended June 30, 2022. "I am proud of the progress we made in the second quarter. As we ramp towards commercial produc

    8/11/22 4:15:00 PM ET
    $RKLY
    Semiconductors
    Technology